Mumbai, November 29, 2017: Shalby Limited (the “Company”) proposes to open, an initial public offering of equity shares of face value of Rs. 10 each (“Equity Shares”) for cash at aPrice including ashare premium (the “Offer”) on Tuesday, December 5, 2017. The Offer comprises comprising afresh issue of Equity Shares aggregating up to Rs. 4,800 million and an Offer For Sale of up to 1,000,000Equity Shares by Dr. Vikram Shah (the “Selling Shareholder”). The Offer comprises a Net Offer to the Public of Equity Shares (the “Net Offer”) and areservation of up to 121,000 Equity Shares for subscription by Eligible Employees. The Offer closes on Thursday, December 7, 2017.The Anchor Investor Bid/Issue Period, if any, shall be one Working Day prior to the Bid/Issue Opening Date.
The Price Band for the Offeris fixed from Rs. 245 to Rs. 248 per Equity Share.
Bids can be made for a minimum lot of 60 Equity Shares and in multiples of 60 Equity Shares thereafter.
The Equity Shares to be offered through theRed Herring Prospectus(“RHP”) dated November 24, 2017 are proposed to be listed on BSE and NSE.
The Book Running Lead Managers (“BRLMs”) to the Offer are Edelweiss Financial Services Limited, IDFC Bank Limited and IIFL Holdings Limited.
Disclaimer
SHALBY LIMITED is proposing, subject to receipt of requisite approvals, market conditions and other considerations, an initial public offering of its Equity Shares and has filed a red herring prospectus with the Registrar of Companies, Gujarat at Ahmedabad (“RHP”). The RHP is available on the website of SEBI at www.sebi.gov.in, and the websites of the Book Running Lead Managers at www.edelweissfin.com. www.idfcbank.com, and www.iiflcap.com.
Any potential investor should note that investment in Equity Shares involves a high degree of risk. For details, potential investors should refer to the section titled “Risk Factors” in the RHP. Investors should not refer to the draft red herring prospectus dated May 19, 2017, for making any investment decision.
The Equity Shares have not been and will not be registered under the Securities Act or any state securities laws in the United States and, unless so registered, and may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in accordance with any and applicable U.S. state securities laws. The Equity Shares are being offered and sold outside the United States in offshore transactions in reliance on Regulation S and the applicable laws of each jurisdiction where such offers and sales are made. The Equity Shares have not been and will not be registered, listed or otherwise qualified in any other jurisdiction outside India and may not be offered or sold, and Bids may not be made by persons in any such jurisdiction, except in compliance with the applicable laws of such jurisdiction.
Capitalised terms not otherwise defined in this press release shall have the meanings ascribed to such terms in the RHP.
For further details contact: Adfactors PR –Rohan Hegde 09820670345, 09820531932
Corporate Comm India(CCI Newswire)
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…